Stockscreener 앱 받기
52.41
2.69%
-1.52
시간 외 거래:
52.41
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine (IRON) to Release Quarterly Earnings on Thursday - Defense World
Disc Medicine’s SWOT analysis: stock poised for growth amid clinical milestones - Investing.com India
Disc medicine director Ashiya Mona sells $16.97 million in stock - Investing.com
Orbimed advisors sells $16.97 million in disc medicine shares - Investing.com
Disc Medicine’s (IRON) Overweight Rating Reiterated at Morgan Stanley - Defense World
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2025. - Marketscreener.com
FY2025 EPS Forecast for Disc Medicine Increased by Analyst - Defense World
Disc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at Scotiabank - MarketBeat
New York State Common Retirement Fund Cuts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Rhumbline Advisers Purchases 1,553 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Price Target Raised to $75.00 at Scotiabank - Defense World
Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know - Yahoo Finance
Disc Medicine price target raised to $75 from $73 at Scotiabank - TipRanks
Leerink Partnrs Comments on Disc Medicine Q1 Earnings - Defense World
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus.com
Disc Medicine (NASDAQ:IRON) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Promising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health - TipRanks
(IRON) Proactive Strategies - Stock Traders Daily
Disc Medicine’s 2024 Financial Results and Clinical Progress - TipRanks
Disc Medicine's Annual Loss Widens in 2024 -February 27, 2025 at 09:33 am EST - Marketscreener.com
TD Cowen Initiates Coverage on Disc Medicine With Buy Rating -February 27, 2025 at 08:31 am EST - Marketscreener.com
Disc Medicine, Inc. SEC 10-K Report - TradingView
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Disc Medicine, Inc. Reports Financial Results and Key Clinical Developments, Targeting NDA Submission for Bitopertin in EPP by H2 2025 - Nasdaq
TD Cowen starts Disc Medicine stock with Buy rating By Investing.com - Investing.com UK
Disc Medicine initiated with a Buy at TD Cowen - TipRanks
How Disc Medicine's $490M War Chest Is Fueling Its Path to First FDA Approval - StockTitan
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Insider Pamela Stephenson Sells 3,137 Shares - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Disc medicine COO Yu sells $87,873 in stock By Investing.com - Investing.com Australia
Disc medicine officer sells shares worth $171,217 By Investing.com - Investing.com Nigeria
Disc Medicine’s chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Nigeria
Disc Medicine's chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Australia
Disc Medicine CEO John Quisel sells $304,228 in stock By Investing.com - Investing.com Nigeria
Disc medicine officer sells shares worth $171,217 - Investing.com India
Disc medicine COO Yu sells $87,873 in stock - Investing.com
Disc Medicine's chief medical officer sells shares worth $89,402 - Investing.com
Disc Medicine CEO John Quisel sells $304,228 in stock - Investing.com
Disc Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Disc Medicine CEO Sells Shares to Cover Tax Obligations - TradingView
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.4% - Defense World
Disc Medicine's SWOT analysis: rare blood disorder stock poised for growth - Investing.com Nigeria
How To Trade (IRON) - Stock Traders Daily
Disc Medicine announces pricing of $225.5M upsized public offering - MSN
Bleakley Financial Group LLC Invests $486,000 in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
FY2025 EPS Estimates for Disc Medicine Increased by Analyst - MarketBeat
Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
0.49%
1.87%
자본화:
|
볼륨(24시간):